Shares of Humana HUM moved higher by 1.2% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 107.60% over the past year to $12.56, which beat the estimate of $10.27.
Revenue of $19,083,000,000 up by 17.47% year over year, which beat the estimate of $18,630,000,000.
Looking Ahead
The upcoming fiscal year's EPS expected to be between $18.25 and $18.75.
How To Listen To The Conference Call
Date: Aug 05, 2020
Time: 09:00 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/hjkb6kut
Recent Stock Performance
52-week high: $412.70
52-week low: $208.25
Price action over last quarter: Up 3.64%
Company Overview
Humana is one of the largest private insurance health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services and pharmacy benefit management.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.